Walleye Capital’s Privia Health PRVA Stock Holding History

Walleye Capital’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,900	Closed	-$47.3K	–	5001
2025 Q3	$47.3K	Buy	+1,900	New	+$40.9K	﹤0.01%	4014

Other funds holding PRVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's PRVA Position: Q4 2025 in Review

Walleye Capital sold out of Privia Health (PRVA) in Q4 2025, closing a stake of 8,397 shares — an estimated $209K sold.

Walleye Capital first reported a position in PRVA in Q4 2021 and held it in 6 quarters. The position peaked at $1.39M in Q3 2023. 276 funds tracked by Wall St. Rank hold PRVA as of Q4 2025.

Walleye Capital reported no remaining Privia Health position as of Q4 2025 after selling out during the quarter.
Walleye Capital sold 8,397 Privia Health shares in Q4 2025, an estimated $209K.
Walleye Capital first reported a position in Privia Health in Q4 2021 and held it in 6 quarters.
Walleye Capital's Privia Health position peaked at $1.39M in Q3 2023.
276 funds tracked by Wall St. Rank held Privia Health as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.